Let's talk medical research

We’ve long followed the Scrip Awards - where the industry’s highest achievers are recognized for outstanding work across the drug development spectrum. And now, we’re thrilled to announce that Antidote has been named a Scrip Awards finalist in two different categories: “Best Technological Development in Clinical Trials,” for our product Antidote Match, and “Community Partnership of the Year” for ...

It’s been an exciting fall here at Antidote. We announced our latest round of funding, grew our partner network to more than 210 partners, and are now finalists for two Scrip Awards. The Scrip Awards provide the industry with the opportunity to recognize its highest achievers across the drug development spectrum— from novel deals, to new drug launches, to technological breakthroughs in clinical ...

November is COPD Awareness Month, a time that COPD patients, caregivers and organizations promote better COPD treatment and the need for research. Nearly 16 million people in the United States have been diagnosed with COPD, and it’s the third leading cause of death in the United States.

National Diabetes Awareness Month is a time to drive awareness of the disease – what it’s like to live with it, what’s the best way to treat it right now, and what research is happening that can give us a glimpse of the future of diabetes treatment and care.

Today is the first day of National Diabetes Awareness Month, and to mark the occasion, we had a conversation with three college students, Hannah, Julie, and Natali, who started their own chapter of the College Diabetes Network at the College of New Jersey.

We interviewed Alice Bast, CEO of Beyond Celiac, about her organization and what's next for celiac disease research.

It’s Mental Illness Awareness Week, a week dedicated to raising awareness of mental illness, which affects approximately 1 in 5 Americans in a given year.

What is Mild Cognitive Impairment? Mild cognitive impairment (MCI) causes slight but noticeable memory changes and thinking problems. These thinking problems are worse than those associated with normal aging, but not as severe as Alzheimer’s disease memory loss symptoms.

Though asthma is a condition that impacts an estimated 27 million Americans, the experience each individual has with it is unique. Depending on the type and severity, managing life with asthma can be a burden — especially if the treatments currently available are not particularly effective.

Our friends at Us Against Alzheimer’s recently announced that 27 Phase III and 8 Phase II Alzheimer’s disease drugs appear on track to launch in the next 5 years. While it remains to be seen which, if any, of these drugs will prove successful, the mere fact that so much Alzheimer’s research is being done is big news for a community made up of 5.4 million individuals who haven’t seen a novel ...